HIMS
Tokyo, meet Hims
Hims & Hers just closed its acquisition of Eucalyptus, the parent company of Juniper, and with that, it’s officially in Japan. Not “thinking about it.” Not “exploring strategic opportunities.” In. Which is a pretty big deal for a company that’s been trying to turn telehealth into a global brand instead of a one-country subscription machine.
Why Japan matters
Japan isn’t just another pin on the map. It’s a massive market with its own healthcare culture, consumer expectations, and regulatory vibes. Hims says it’s bringing its tech, data, and clinical infrastructure to support weight management care there, which is basically the company saying: “We think our playbook travels.”
For investors, the appeal is obvious:
- more geography = more growth runway
- more users = more data to improve the platform
- more international scale = less reliance on one market
The catch, because there’s always a catch
Crossing borders sounds glamorous until you remember that healthcare is not Uber for pills. Local rules, consumer habits, and medical norms can turn expansion plans into a slow-burn slog. Japan could be a real growth engine — or a reminder that winning in one market doesn’t automatically mean you can copy-paste success elsewhere.
Still, this is the kind of acquisition that tells you management is aiming higher than incremental domestic growth. Big picture: Hims & Hers wants to be a global health platform, and Japan is its latest proof point.